Clinical Trial Update: Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating subcutaneous injections of ASC to heal digital ulcers in systemic sclerosis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• ASC (adipose-derived stromal cells) (adipose-derived stromal cells)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Systemic Sclerosis | Phase 2 | Status: RECRUITING